Nomura Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34.5M | Sell |
431,084
-948
| -0.2% | -$78.2K | 0.09% | 238 |
|
|
2025
Q4 | $36.8M | Buy |
432,032
+68,673
| +19% | +$5.64M | 0.09% | 223 |
|
|
2025
Q3 | $28.3M | Buy |
363,359
+149,119
| +70% | +$11.7M | 0.07% | 258 |
|
|
2025
Q2 | $16.8M | Sell |
214,240
-10,066
| -4% | -$751K | 0.05% | 336 |
|
|
2025
Q1 | $16.3M | Buy |
224,306
+7,789
| +4% | +$557K | 0.05% | 322 |
|
|
2024
Q4 | $16M | Buy |
216,517
+15,014
| +7% | +$1.05M | 0.05% | 321 |
|
|
2024
Q3 | $13.3M | Sell |
201,503
-75,957
| -27% | -$5.52M | 0.04% | 344 |
|
|
2024
Q2 | $25.6M | Buy |
277,460
+23,967
| +9% | +$2.12M | 0.09% | 222 |
|
|
2024
Q1 | $24.2M | Buy |
253,493
+11,055
| +5% | +$929K | 0.09% | 230 |
|
|
2023
Q4 | $18.5M | Sell |
242,438
-177,692
| -42% | -$12.4M | 0.08% | 254 |
|
|
2023
Q3 | $29.1M | Sell |
420,130
-44,371
| -10% | -$3.57M | 0.14% | 182 |
|
|
2023
Q2 | $43.8M | Buy |
464,501
+75,748
| +19% | +$6.58M | 0.2% | 116 |
|
|
2023
Q1 | $32.2M | Buy |
388,753
+91,967
| +31% | +$7.23M | 0.17% | 142 |
|
|
2022
Q4 | $22.1M | Sell |
296,786
-6,160
| -2% | -$475K | 0.13% | 180 |
|
|
2022
Q3 | $25M | Buy |
302,946
+8,087
| +3% | +$778K | 0.16% | 145 |
|
|
2022
Q2 | $28M | Buy |
294,859
+45,883
| +18% | +$4.75M | 0.18% | 127 |
|
|
2022
Q1 | $29.3M | Buy |
248,976
+5,075
| +2% | +$569K | 0.16% | 137 |
|
|
2021
Q4 | $31.6M | Buy |
243,901
+118,797
| +95% | +$13.9M | 0.16% | 135 |
|
|
2021
Q3 | $14.2M | Buy |
125,104
+3,667
| +3% | +$419K | 0.08% | 246 |
|
|
2021
Q2 | $12.6M | Buy |
121,437
+3,672
| +3% | +$346K | 0.07% | 268 |
|
|
2021
Q1 | $9.85M | Buy |
117,765
+3,048
| +3% | +$258K | 0.06% | 302 |
|
|
2020
Q4 | $10.5M | Buy |
114,717
+4,620
| +4% | +$383K | 0.07% | 267 |
|
|
2020
Q3 | $8.79M | Sell |
110,097
-2,027
| -2% | -$158K | 0.07% | 263 |
|
|
2020
Q2 | $7.75M | Sell |
112,124
-1,261
| -1% | -$89.6K | 0.07% | 263 |
|
|
2020
Q1 | $7.13M | Buy |
113,385
+10,914
| +11% | +$787K | 0.07% | 238 |
|
|
2019
Q4 | $7.97M | Sell |
102,471
-3,090
| -3% | -$241K | 0.07% | 261 |
|
|
2019
Q3 | $7.74M | Buy |
105,561
+8,043
| +8% | +$565K | 0.07% | 256 |
|
|
2019
Q2 | $6M | Sell |
97,518
-54,390
| -36% | -$3.29M | 0.06% | 287 |
|
|
2019
Q1 | $9.69M | Sell |
151,908
-6,657
| -4% | -$380K | 0.1% | 193 |
|
|
2018
Q4 | $8.1M | Buy |
158,565
+4,260
| +3% | +$216K | 0.09% | 212 |
|
|
2018
Q3 | $8.95M | Buy |
154,305
+63,342
| +70% | +$3.1M | 0.09% | 208 |
|
|
2018
Q2 | $4.41M | Buy |
90,963
+2,490
| +3% | +$116K | 0.05% | 317 |
|
|
2018
Q1 | $4.12M | Buy |
88,473
+3,246
| +4% | +$141K | 0.04% | 319 |
|
|
2017
Q4 | $3.2M | Sell |
85,227
-37,407
| -31% | -$1.37M | 0.04% | 385 |
|
|
2017
Q3 | $4.47M | Buy |
+122,634
| New | +$4.68M | 0.06% | 284 |
|
|
2017
Q2 | – | Sell |
-75,330
| Closed | -$2.36M | – | 956 |
|
|
2017
Q1 | $2.36M | Buy |
75,330
+5,040
| +7% | +$158K | 0.03% | 419 |
|
|
2016
Q4 | $2.2M | Sell |
70,290
-2,130
| -3% | -$69K | 0.04% | 401 |
|
|
2016
Q3 | $2.91M | Buy |
72,420
+1,770
| +3% | +$66.7K | 0.05% | 336 |
|
|
2016
Q2 | $2.35M | Sell |
70,650
-25,956
| -27% | -$888K | 0.04% | 376 |
|
|
2016
Q1 | $2.84M | Buy |
96,606
+28,926
| +43% | +$798K | 0.05% | 323 |
|
|
2015
Q4 | $1.78M | Buy |
67,680
+1,740
| +3% | +$45.2K | 0.03% | 420 |
|
|
2015
Q3 | $1.56M | Buy |
65,940
+2,760
| +4% | +$66.6K | 0.03% | 448 |
|
|
2015
Q2 | $1.5M | Hold |
63,180
| – | – | 0.03% | 470 |
|
|
2015
Q1 | $1.5M | Sell |
63,180
-2,100
| -3% | -$47.1K | 0.03% | 476 |
|
|
2014
Q4 | $1.41M | Sell |
65,280
-600
| -0.9% | -$12.1K | 0.02% | 486 |
|
|
2014
Q3 | $1.12M | Sell |
65,880
-2,400
| -4% | -$37.9K | 0.02% | 533 |
|
|
2014
Q2 | $977K | Sell |
68,280
-6,000
| -8% | -$81.3K | 0.02% | 587 |
|
|
2014
Q1 | $918K | Sell |
74,280
-1,680
| -2% | -$19.4K | 0.02% | 594 |
|
|
2013
Q4 | $833K | Sell |
75,960
-9,780
| -11% | -$110K | 0.02% | 620 |
|
|
2013
Q3 | $995K | Buy |
85,740
+2,400
| +3% | +$28.1K | 0.02% | 556 |
|
|
2013
Q2 | $933K | Buy |
+83,340
| New | +$986K | 0.02% | 585 |
|
Other funds holding EW
VCM
VPM
Nomura Asset Management's EW Position: Q1 2026 in Review
Nomura Asset Management reduced its Edwards Lifesciences (EW) stake by 0.22% in Q1 2026, selling an estimated $78.2K and leaving 431,084 shares worth $34.5M. The position accounts for 0.09% of the portfolio, ranked #238.
Nomura Asset Management first reported a position in EW in Q2 2013 and has held it in 51 quarters since. The position peaked at $43.8M in Q2 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Nomura Asset Management held 431,084 shares of Edwards Lifesciences worth $34.5M as of Q1 2026.
- Nomura Asset Management sold 948 Edwards Lifesciences shares in Q1 2026, an estimated $78.2K.
- Edwards Lifesciences made up 0.09% of Nomura Asset Management's portfolio in Q1 2026, its #238 holding.
- Nomura Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
- Nomura Asset Management's Edwards Lifesciences position peaked at $43.8M in Q2 2023.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Nomura Asset Management's 13F filing for Q1 2026, filed 11 May 2026.